Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


More On

Bellwether cases selected in transvaginal mesh litigation

First trial concerning C.R. Bard product scheduled for June 11

Litigation concerning complications from transvaginal mesh products is continuing to move forward.

Earlier this month, the District Court for the Southern District of Virginia issued an order selecting four lawsuits for bellwether trials in litigation concerning C.R. Bard Inc.’s Avaulta mesh products. The first bellwether trial is slated to begin on June 11.

In layman’s terms, bellwether trials are the first cases to be tried in a group of similar cases. Typically, these trials set the trend in terms of how similar cases might transpire.

In the cases, women claim the mesh products, which are designed to support organs in the pelvic region that have shifted due to weakened or stretched muscles, often from childbirth, caused complications such as infection, incontinence, and abdominal, pelvic and vaginal pain.

Other transvaginal mesh federal litigation concerning C.R. Bard, American Medical Systems Inc., Boston Scientific Corp. and Ethicon Inc. products is also underway in the Southern District of West Virginia, and more than 1,000 suits are pending in consolidated proceedings in New Jersey Superior Court.

Earlier this month, the country’s first trial involving Ethicon’s mesh product resulted in a jury awarding more than $11 million to the plaintiff, including $7.76 million in punitive damages.

For more InsideCounsel coverage of surgical mesh news, read:

Government investigates J&J’s hip devices, surgical mesh

States launch investigation into sales of Boston Scientific surgical mesh

Surgical mesh litigation moves forward

FDA-approved surgical mesh faces review

Ashley Post

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.